Pet Dewormers Industry Snapshot
The global Pet Dewormers market was valued at USD 1.73 billion in 2024 and is set to reach USD 3.16 billion by 2034, growing at a steady CAGR of 6.92%.
Pet Dewormers are medications that prevent or treat parasitic worm infections in pets, especially dogs and cats. The parasites can be roundworms, hookworms, tapeworms, or whipworms. Pet dewormers come in various forms, including tablets, chewables, liquids, and topical solutions, and play a key role in keeping pets healthy, stopping parasites from spreading to humans, and generally for well-being. The market is fueled by the rising pet ownership globally, growing concern for pet health, and increasing emphasis on preventative care. As individuals become more aware of their pets' health and well-being, demand for deworming products has increased.
The increasing adoption of veterinary care, coupled with the development of pet pharmaceuticals, has also fueled the growth of the market. The market is also impacted by other considerations, including growing awareness of zoonotic diseases (diseases transmitted from animals to humans), which have increased the relevance of deworming drugs. With pet owners looking for simple and effective treatments, the market for pet dewormers remains on the rise, with market leaders providing innovative products to cater to the changing needs of pet care.
Pet Dewormers Market Report Scope
|
Report Attribute
|
Details
|
|
Market Value (2024)
|
USD 1.73 Billion
|
|
Projected Market Value (2034)
|
USD 3.16 Billion
|
|
Base Year
|
2024
|
|
Historical Year
|
2020-2023
|
|
Forecast Years
|
2025 – 2034
|
|
Scope of the Report
|
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Based on By Product Type, By Animal Type, By End User, By Formulation, By Distribution Channel, & Region.
|
|
Quantitative Units
|
Revenue in USD million/billion and CAGR from 2025 to 2034.
|
|
Report Coverage
|
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis.
|
|
Delivery Format
|
Delivered as an attached PDF and Excel through email, according to the purchase option.
|
Dynamic Insights
A rising number of pet owners globally is the main stimulant. More and more individuals are adopting pets, which have fueled demand for products that ensure their well-being, such as dewormers. Pet owners are now taking the threats presented by parasites into account and ensuring they deworm them regularly, thereby boosting adoption of products. Further, growth in preventive veterinary healthcare and accessibility of veterinary clinics have helped dewormer demand boom. Another important influence is the escalating concern for pet health and wellness, which resulted in higher outlays on pet care products.
Zoonosis awareness, such as diseases which can be carried from pets to humans, also caused pet owners to invest on deworming medication to keep their pets, as well as their families, safe. Technological innovation in dewormer formulations and the availability of more efficient, convenient-to-administer products, including chewable tablets and spot-on formulations, are serving to increase the market even further. Yet the market is plagued by challenges, such as the presence of substandard or fake products and possible resistance of parasites to some dewormers. Notwithstanding the challenges, the market is still expanding due to innovation and demand for pet health products.
Core Drivers
-
Increase in Pet Ownership
The increasing pet adoption trend, especially in developing countries, is among the key factors driving the market for pet dewormers. An increasing number of people are adopting pets because of the strengthened human-animal bond, and pets are now considered family members. The rising pet ownership rate, especially among millennials and Generation Z, has had a direct influence on pet care product demand, including dewormers. Since pets are part of the family, owners are more conscious of their health requirements, including safeguarding against parasitic infections. This awareness results in a consistent rise in the sale of deworming products as pet owners look for ways to prevent and cure parasitic infestations.
-
Rising Awareness of Preventative Pet Care
Preventive care is becoming the major priority of pet owners all over the world, with many of them now giving priority to preventive care, including deworming medications, to maintain their pets' long-term health. This transition from reactive to proactive care has led to frequent use of dewormers to avoid parasitic infections that can result in severe health issues.
Veterinary experts and pet care organizations have also contributed by making pet owners aware of the need for regular deworming, particularly in areas where pets are more likely to be exposed to infections based on environmental conditions. This greater emphasis on preventive care is driving the growth of the pet dewormers market.
Market Constraints
-
Availability of Counterfeit Products
One of the major challenges facing the pet dewormers market is the widespread availability of counterfeit or low-quality deworming products. These substandard products can pose significant health risks to pets and may not effectively eliminate parasites. The presence of counterfeit goods undermines consumer confidence and poses challenges for regulatory bodies in maintaining product quality and safety standards. The market for counterfeit dewormers is especially prevalent in regions with weak regulatory frameworks, hindering growth in certain parts of the world.
Parasites, such as worms, have shown increasing resistance to certain types of deworming medications. This phenomenon can make traditional treatments less effective over time, limiting their ability to provide lasting protection for pets. The rising resistance among parasites to commonly used dewormers is concerning for both pet owners and veterinarians, as it can lead to recurring infestations and the need for stronger, potentially more expensive treatments. This issue complicates the effectiveness of the products in the market and presents a challenge to manufacturers in ensuring long-term efficacy.
Future Potential
-
Innovation in Product Offerings
Technological innovations and product development in the pet dewormers market provide immense growth prospects. Companies are working towards creating new products that are not only more efficient but also easier to consume for pets. Flavored chewables, liquid-based products, and topical products are innovations aimed at making deworming easier for pets and their owners alike.
In addition, innovation in personalized deworming products based on pets' individual needs and health profiles may offer prospects for tailored treatments, boosting market growth and customer satisfaction. With pet owners seeking more convenient and effective means of caring for their pets, innovation in deworming products can fuel demand and enhance overall product uptake.
Market Segmentation Overview
By Product Type segment of the global pet dewormers market includes various product formulations intended for various administration routes. Tablets, oral suspensions, topical solutions, and injectables each have specific purposes depending on ease of administration and the nature of the parasite to be treated. Tablets are the most popular form, providing convenience and efficacy for the majority of pets.
Oral suspensions are generally for pets with a hard time swallowing tablets, while topical application is applied directly to the pet's skin and is commonly preferred for flea and tick control and deworming. Injectables, although not as popular, are utilized for heavy infestations or in pets needing a more regulated dosage. The diversification of product types guarantees that pet owners enjoy convenient choices depending on the particular requirements of their pets.
The By Animal Type segment covers products tailored for different pets, including dogs, cats, and other pets like rabbits, birds, and exotic animals. The market is predominantly driven by the pet deworming needs of dogs and cats, as these are the most common pets owned globally. However, as pet ownership expands to include a variety of other animals, such as rabbits or birds, the demand for deworming solutions for these animals is also growing. These pets may require specialized formulations or treatment methods, adding diversity to the market and expanding the available product offerings.
The By End-User category comprises veterinary clinics, animal hospitals, pet stores, and online sales. Veterinary clinics and animal hospitals are the major end-users of deworming products since they offer healthcare services to pets, such as diagnosis and treatment of parasitic infestations. Pet stores are a retail outlet for over-the-counter dewormers, selling products directly to customers. The online channel has recorded strong growth from the convenience presented by e-commerce platforms that enable pet owners to buy dewormers at home. This segment indicates the various touchpoints where deworming products are being distributed and the emerging trend of more buying done online.
In the By Formulation segment, pet dewormers are categorized into prescription-based and over-the-counter (OTC) products. Prescription-based dewormers are typically prescribed by veterinarians after diagnosing a pet’s specific condition, often for more serious or persistent infestations. These dewormers are highly regulated and are considered stronger or more targeted treatments.
On the other hand, OTC dewormers are widely available without a prescription, offering pet owners an easy, over-the-counter option for routine deworming. OTC products are generally used for mild to moderate infestations and offer a less expensive alternative for pet owners seeking preventive care.
By Distribution Channel segment categorizes the market as offline and online channels. Offline distribution channels refer to offline physical stores like veterinary clinics, pet stores, and pharmacies, from which pet owners can directly buy deworming products. Though offline channels dominate in most markets, offline sales have been on the verge of explosive growth following the upsurge in e-commerce websites.
Online channels offer increased convenience and availability of a wide range of products, enabling pet owners to shop around for prices and specific formulations. The transition towards online purchasing has become extremely common in the context of the COVID-19 pandemic, with consumers preferring increasingly to buy health-related products online for pets. Having both offline and online channels combined provides access to deworming solutions for a global market.
Regional Overview
North America has a mature market, boosted by high ownership levels of dogs and cats, as well as a high awareness of pet health. Most owners in the region use deworming treatment as a routine preventative measure against parasitic infestation. The biggest market in North America, the United States, is also reporting strong demand for prescription and over-the-counter deworming medicines. Besides, the prevalence of e-commerce has highly increased online purchases, providing more convenience to the consumers. In the same vein, Europe also has a mature pet care industry, with nations such as the UK, Germany, and France being at the forefront.
Rising pet ownership and veterinary practice trends are driving the deworming market growth. European consumers are increasingly predisposed to preventive health, further raising the demand for dewormers. In the Asia-Pacific region, the market is growing fast on the back of rising disposable income, growing adoption of pets, and heightened sensitivity to pet health. China, Japan, and India are particularly growing fast at the pet adoption rate, generating more demand for pet care items such as dewormers.
As more people adopt pets are increasingly aware of deworming importance, the focus is switching to preventive treatment. Latin America is led by Brazil and Mexico, the larger markets where pet ownership is similarly increasing and rising interest in pet healthcare is driving demand for deworming solutions. The MEA region is developing but exhibiting growth prospects in the UAE and South Africa due to rising prosperous pet owners and enhancing veterinary infrastructure.
Market Player Analysis
Market leaders are dominated by big pharma firms, which include popular names like Zoetis, Merck & Co., Bayer AG, Elanco Animal Health, and Boehringer Ingelheim. They utilize their huge research and development strength to bring in new deworming products that are more effective and easier to administer to pets. These stores usually have a wide variety of deworming drugs, ranging from prescription dewormers to over-the-counter medications, that deal with various kinds of pets, such as dogs, cats, and others.
The industry is also seeing a growing number of smaller regional players, who are concentrating on broadening their product ranges and penetrating emerging markets. These firms tend to provide specialized formulations for specific parasitic infections, like tapeworms or roundworms, and are gaining traction in markets with less stringent regulations. Further, the growth of e-commerce platforms has provided new opportunities for competition, allowing large brands and smaller companies to gain access to more customers. Consumer education and awareness are also areas of focus for companies, driving the value proposition of deworming treatment regularly.
Strategic collaborations and alliances with veterinary clinics, pet shops, and online sites are emerging as market differentiators. The rise in the direction of online channels for sales has compelled businesses to upgrade their online presence, providing convenience and hassle-free shopping experience for pet owners. In spite of the market leadership of the major players, the market still continues to transform due to product innovation, competitive pricing, and regional offerings to address the heterogeneous demands of the global pet care market.
Leading Companies
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Vetoquinol S.A.
- Neogen Corporation
- Intas Pharmaceuticals Ltd.
- PetIQ, Inc.
- Virbac
- Dechra Pharmaceuticals PLC
- Bayer AG
- Merck & Co., Inc.
- Cipla Limited
- Beaphar
- Krka, d. d., Novo mesto
- Elanco Animal Health Incorporated
- Phibro Animal Health Corporation
- Ceva Santé Animale
- Zydus Animal Health and Investments Limited
- Norbrook Laboratories Limited
- Chanelle Pharma Group
- Huvepharma
Pet Dewormers Market Segmentation
By Product Type
- Tablets
- Oral Suspensions
- Topical Treatments
- Injectables
By Animal Type
By End-User
- Veterinary Clinics
- Animal Hospitals
- Pet Stores
- Online Sales
By Formulation
- Prescription-Based Dewormers
- Over-the-Counter Dewormers
By Distribution Channel
By Region
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Saudi Arabia
- Kuwait
- UAE
- Rest of Middle East & Africa
Objectives of the Study
The study focuses on analyzing the global Pet Dewormers market through the following key objectives:
- Market Sizing and Forecasting: Estimate the market size and growth for Pet Dewormers By Product Type, By Animal Type, By End User, By Formulation, By Distribution Channel, and Region from 2025 to 2034.
- Market Dynamics and Trends: Analyze key drivers, challenges, and opportunities shaping the market, along with evolving consumer preferences and fashion trends.
- Consumer Insights: Understand factors influencing consumer behavior, including brand perception, sustainability, and regional differences.
- Competitive Landscape: Profile major players with insights into financial performance, product portfolios, SWOT analysis, and strategic initiatives.
- Strategic Recommendations: Identify future trends, technologies, and actionable strategies for stakeholders to drive growth and address challenges effectively.
+1 812 506 4440
+39 3349953425
+91 9270434043
sales@metricwaveinsights.com
Ask For Discount
Enquiry Before Buy
Ask For Customization
